Business Context and Reporting Period
Company: Herbalife Ltd.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2006
Business Overview: Herbalife is a global network marketing company selling weight management, nutritional supplements ("Inner Nutrition"), and personal care products ("Outer Nutrition") through over one million independent distributors in 62 countries. The company operates as a single reporting segment.
Key Financial Metrics
| Metric (in millions) | Three Months Ended June 30, 2006 |
Six Months Ended June 30, 2006 |
|---|---|---|
| Net Sales | $466.0 | $921.8 |
| Gross Profit | $373.3 | $737.8 |
| Gross Margin | 80.1% | 80.0% |
| Operating Income | $65.1 | $129.2 |
| Net Income | $36.3 | $75.0 |
| Diluted EPS | $0.49 | $1.01 |
| Operating Cash Flow | N/A | $102.4 |
| Cash and Equivalents | $169.3 | $169.3 |
| Total Debt (Long-term + Current) | $247.9 | $247.9 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 21.1% for the quarter and 21.8% for the six-month period compared to 2005. Growth was driven primarily by the Americas (up 39.2% Q/Q) and Asia/Pacific Rim (up 24.7% Q/Q), partially offset by a decline in Japan (down 6.4% Q/Q).
- Profitability: Net income rose 59.5% for the quarter and 107.8% for the six-month period year-over-year. This was driven by sales growth, lower interest expense, and a reduced effective tax rate (36.5% for six months 2006 vs. 51.2% in 2005).
- Interest Expense: Net interest expense decreased significantly to $5.0 million for the quarter and $11.0 million for the six months, compared to $7.4 million and $29.6 million in 2005, due to debt prepayments and the redemption of 40% of the 9 1/2% Notes in early 2005.
- Stock-Based Compensation: The company adopted SFAS No. 123R effective January 1, 2006. This resulted in a $5.5 million expense for the six months ended June 30, 2006, reducing net income by $2.8 million compared to the previous accounting method.
Guidance, Outlook, and Risks
- Capital Expenditures: The company expects to incur approximately $55.0 million in capital expenditures for 2006, focusing on IT systems, direct-to-consumer platforms, and facility expansion in China and the U.S.
- China Expansion: The company anticipates funding an operating loss of approximately $4.5 million in China for 2006, alongside capital expenditures for retail store build-outs.
- Debt Refinancing (Subsequent Event): On July 21, 2006, the company entered into a new $300.0 million senior secured credit facility to replace the existing $225.0 million facility. Proceeds will be used to redeem the remaining $165.0 million of 9 1/2% Notes on August 23, 2006. This redemption is expected to incur an after-tax one-time charge of approximately $14.0 million.
- Legal Contingencies: The company is a defendant in class action lawsuits regarding distributor marketing practices (Minton v. Herbalife) and telemarketing violations (Mey v. Herbalife). Management believes it has meritorious defenses and does not expect a material impact on financial condition.
- Regulatory Risks: Significant risks include compliance with direct selling regulations in China, potential FDA regulations on dietary supplements (cGMPs), and FTC proposed rules on business opportunities.
Investor Verification Checklist
- Debt Redemption Impact: Verify the timing and exact cost of the $14.0 million one-time charge associated with the August 2006 redemption of the 9 1/2% Notes.
- China Operations: Monitor the progress of the retail store expansion in China and the ability to secure necessary regulatory licenses for direct selling.
- Distributor Turnover: Review future reports on supervisor re-qualification rates and distributor retention, as high turnover is a key risk factor.
- Legal Proceedings: Track the status of the Minton and Mey class action lawsuits, specifically regarding class certification and potential vicarious liability.
- Foreign Exchange: Assess the impact of currency fluctuations, as approximately 82% of sales are generated outside the U.S., creating exposure to exchange rate volatility.